These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Umbilical Cord-Derived Mesenchymal Stem Cells Are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications. Tesarova L; Jaresova K; Simara P; Koutna I Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731615 [TBL] [Abstract][Full Text] [Related]
24. The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice. Yin Y; Hao H; Cheng Y; Gao J; Liu J; Xie Z; Zhang Q; Zang L; Han W; Mu Y Int Immunopharmacol; 2018 Jul; 60():235-245. PubMed ID: 29778021 [TBL] [Abstract][Full Text] [Related]
25. Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients. Ma L; Zhou Z; Zhang D; Yang S; Wang J; Xue F; Yang Y; Yang R Thromb Haemost; 2012 May; 107(5):937-50. PubMed ID: 22398715 [TBL] [Abstract][Full Text] [Related]
26. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice. Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846 [TBL] [Abstract][Full Text] [Related]
27. Human umbilical cord mesenchymal stem cells derived exosomes exert antiapoptosis effect via activating PI3K/Akt/mTOR pathway on H9C2 cells. Liu H; Sun X; Gong X; Wang G J Cell Biochem; 2019 Sep; 120(9):14455-14464. PubMed ID: 30989714 [TBL] [Abstract][Full Text] [Related]
28. Umbilical cord-mesenchymal stem cells induce a memory phenotype in CD4 Sengun E; Wolfs TGAM; van Bruggen VLE; van Cranenbroek B; Simonetti ER; Ophelders D; de Jonge MI; Joosten I; van der Molen RG Front Immunol; 2023; 14():1128359. PubMed ID: 37409122 [TBL] [Abstract][Full Text] [Related]
29. Role of VEGF-A in angiogenesis promoted by umbilical cord-derived mesenchymal stromal/stem cells: in vitro study. Arutyunyan I; Fatkhudinov T; Kananykhina E; Usman N; Elchaninov A; Makarov A; Bolshakova G; Goldshtein D; Sukhikh G Stem Cell Res Ther; 2016 Mar; 7():46. PubMed ID: 27001300 [TBL] [Abstract][Full Text] [Related]
31. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Friedman R; Betancur M; Boissel L; Tuncer H; Cetrulo C; Klingemann H Biol Blood Marrow Transplant; 2007 Dec; 13(12):1477-86. PubMed ID: 18022578 [TBL] [Abstract][Full Text] [Related]
32. Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation. Selich A; Zimmermann K; Tenspolde M; Dittrich-Breiholz O; von Kaisenberg C; Schambach A; Rothe M Stem Cell Res Ther; 2019 Sep; 10(1):285. PubMed ID: 31547865 [TBL] [Abstract][Full Text] [Related]
33. Serum-free human MSC medium supports consistency in human but not in equine adipose-derived multipotent mesenchymal stromal cell culture. Schubert S; Brehm W; Hillmann A; Burk J Cytometry A; 2018 Jan; 93(1):60-72. PubMed ID: 28926198 [TBL] [Abstract][Full Text] [Related]
34. [Effects of Exosomes Derived from miR-486 Gene Modified Umbilical Cord Mesenchymal Stem Cells on Biological Characteristics of Rat Cardiomyocytes]. Fang L; Shi XF; Sun HY; Li YX; Xiao FJ; Wang H; Wang LS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1531-1537. PubMed ID: 30295279 [TBL] [Abstract][Full Text] [Related]
35. Umbilical cord mesenchymal stromal cell transplantations: A systemic analysis of clinical trials. Can A; Celikkan FT; Cinar O Cytotherapy; 2017 Dec; 19(12):1351-1382. PubMed ID: 28964742 [TBL] [Abstract][Full Text] [Related]
36. Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice. Mai S; Zou L; Tian X; Liao X; Luan Y; Han X; Wei Y; Wu Y; Kuang S; Yang Y; Ma J; Chen Q; Yang J Mol Pharm; 2018 May; 15(5):1800-1813. PubMed ID: 29668284 [TBL] [Abstract][Full Text] [Related]
37. Secreted galectin-3 as a possible biomarker for the immunomodulatory potential of human umbilical cord mesenchymal stromal cells. Liu GY; Xu Y; Li Y; Wang LH; Liu YJ; Zhu D Cytotherapy; 2013 Oct; 15(10):1208-17. PubMed ID: 23850421 [TBL] [Abstract][Full Text] [Related]
38. Diverse impact of xeno-free conditions on biological and regenerative properties of hUC-MSCs and their extracellular vesicles. Bobis-Wozowicz S; Kmiotek K; Kania K; Karnas E; Labedz-Maslowska A; Sekula M; Kedracka-Krok S; Kolcz J; Boruczkowski D; Madeja Z; Zuba-Surma EK J Mol Med (Berl); 2017 Feb; 95(2):205-220. PubMed ID: 27638341 [TBL] [Abstract][Full Text] [Related]
39. Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells. Zhao Q; Ren H; Li X; Chen Z; Zhang X; Gong W; Liu Y; Pang T; Han ZC Cytotherapy; 2009; 11(4):414-26. PubMed ID: 19513901 [TBL] [Abstract][Full Text] [Related]